ReviewTranslational lung cancer research2023

Narrative review: immunotherapy in anaplastic lymphoma kinase (ALK)+ lung cancer-current status and future directions.

Erin L SchenkPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.